Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guizhi Fuling Capsule for uterine fibroids
ChiCTR-TRC-12002913Phase 4Recruiting
- Sponsor
- West China Second University Hospital
- Start
- Dec 2012
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of guizhi fuling wan in Fibromyoma (LM) (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Quality of life and Reduction in uterine fibroid size. Started Dec 2012; status: recruiting.
02
Drugs
guizhi fuling wan
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR-TRC-12002913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002913.